Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.71B |
| 2 |
Microsoft
MSFT
|
+$3.52B |
| 3 |
Amazon
AMZN
|
+$2.04B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$1.87B |
| 5 |
Eli Lilly
LLY
|
+$1.31B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.8B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.78B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$703M |
| 4 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$611M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.3% |
| 2 | Healthcare | 12.11% |
| 3 | Financials | 10.63% |
| 4 | Consumer Discretionary | 8.09% |
| 5 | Industrials | 6.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4326
OFS Capital
OFS
$51.9M
| $2.09M | ﹤0.01% |
205,951
-82,755
| -29% | -$810K |
|
4327
MBIA
MBI
$260M
| $2.09M | ﹤0.01% |
162,583
-541,389
| -77% | -$6.18M |
|
4328
Scully Royalty
SRL
$87.1M
| $2.08M | ﹤0.01% |
270,313
-3,152
| -1% | -$24.5K |
|
4329
Garrett Motion
GTX
$5.57B
| $2.08M | ﹤0.01% |
272,505
+40,820
| +18% | +$287K |
|
|
AXIA.PR
4330
DELISTED
AXIA Energia American Depositary Shares Preferred Class B1
AXIA.PR
| $2.08M | ﹤0.01% |
319,560
+48,254
| +18% | +$351K |
|
4331
Dole
DOLE
$1.32B
| $2.08M | ﹤0.01% |
215,026
-164,035
| -43% | -$1.49M |
|
4332
Invesco Floating Rate Municipal Income ETF
PVI
$32.3M
| $2.07M | ﹤0.01% |
83,047
+20,413
| +33% | +$509K |
|
|
MILN
4333
Global X Millennial Consumer ETF
MILN
$103M
| $2.07M | ﹤0.01% |
79,183
-14,954
| -16% | -$401K |
|
4334
Winmark
WINA
$1.32B
| $2.05M | ﹤0.01% |
8,713
+1,147
| +15% | +$273K |
|
|
BNR
4335
Burning Rock Biotech
BNR
$92.9M
| $2.05M | ﹤0.01% |
91,201
-298
| -0.3% | -$6.8K |
|
4336
Aemetis
AMTX
$124M
| $2.05M | ﹤0.01% |
517,943
+38,246
| +8% | +$217K |
|
4337
Future Fuel
FF
$223M
| $2.05M | ﹤0.01% |
252,155
+11,703
| +5% | +$88.4K |
|
4338
Invesco S&P SmallCap Consumer Staples ETF
PSCC
$39.1M
| $2.05M | ﹤0.01% |
60,243
-49,557
| -45% | -$1.71M |
|
4339
Arcturus Therapeutics
ARCT
$211M
| $2.05M | ﹤0.01% |
120,628
+36,042
| +43% | +$628K |
|
4340
TriplePoint Venture Growth BDC
TPVG
$211M
| $2.04M | ﹤0.01% |
195,529
+15,235
| +8% | +$184K |
|
|
PLYM
4341
DELISTED
Plymouth Industrial REIT
PLYM
| $2.04M | ﹤0.01% |
106,261
+26,389
| +33% | +$500K |
|
4342
Heron Therapeutics
HRTX
$92.9M
| $2.03M | ﹤0.01% |
811,901
-134,412
| -14% | -$433K |
|
|
CVAC
4343
DELISTED
CureVac
CVAC
| $2.03M | ﹤0.01% |
336,606
+17,311
| +5% | +$128K |
|
|
IAE
4344
Voya Asia Pacific High Dividend Equity Income Fund
IAE
$93.1M
| $2.03M | ﹤0.01% |
330,911
-2,016
| -0.6% | -$12.1K |
|
|
PNF
4345
DELISTED
PIMCO New York Municipal Income Fund
PNF
| $2.02M | ﹤0.01% |
224,123
-15,073
| -6% | -$129K |
|
4346
BlackRock MuniYield Pennsylvania Quality Fund
MPA
$144M
| $2.02M | ﹤0.01% |
183,674
+21,333
| +13% | +$234K |
|
|
ATRI
4347
DELISTED
Atrion Corp
ATRI
| $2.02M | ﹤0.01% |
3,613
-235
| -6% | -$142K |
|
|
TRVG
4348
trivago
TRVG
$397M
| $2.02M | ﹤0.01% |
298,833
+41,433
| +16% | +$254K |
|
|
RFP
4349
DELISTED
Resolute Forest Products Inc.
RFP
| $2.01M | ﹤0.01% |
93,308
-160,784
| -63% | -$3.36M |
|
|
GTHX
4350
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $2.01M | ﹤0.01% |
370,673
+32,379
| +10% | +$271K |
|
Similar funds
Morgan Stanley's Q4 2022 Portfolio in Review
As of Q4 2022, Morgan Stanley held 8,205 positions worth $880B, up 20% from $734B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Morgan Stanley deployed $97B of net new capital in Q4 2022, opening 199 new positions and adding to 3,814 existing holdings. Its largest new stake was Rentokil: 2,829,958 shares worth $87.2M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.8B trimmed.
- Morgan Stanley's largest Q4 2022 buy was Rentokil: 2,829,958 shares worth $87.2M.
- Morgan Stanley added most to Apple in Q4 2022, an estimated $3.71B increase.
- Morgan Stanley's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.8B.
- Morgan Stanley fully exited Twitter, Inc. in Q4 2022, selling an estimated $348M.
- Morgan Stanley's ten largest holdings make up 14% of its $880B portfolio in Q4 2022.
- Morgan Stanley opened 199 new positions and closed 311 in Q4 2022.
- Morgan Stanley's portfolio value rose 20% quarter-over-quarter to $880B.
Based on Morgan Stanley's 13F filing for Q4 2022, filed 14 Feb 2023.